Wall Street brokerages forecast that Limoneira (NASDAQ:LMNR) will announce sales of $25.05 million for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for Limoneira’s earnings. The highest sales estimate is $26.90 million and the lowest is $23.20 million. Limoneira reported sales of $14.71 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 70.3%. The company is scheduled to report its next quarterly earnings results on Monday, January 13th.
On average, analysts expect that Limoneira will report full-year sales of $159.66 million for the current financial year, with estimates ranging from $157.50 million to $161.82 million. For the next year, analysts anticipate that the firm will post sales of $201.25 million, with estimates ranging from $197.00 million to $205.50 million. Zacks’ sales calculations are an average based on a survey of research firms that follow Limoneira.
Several equities research analysts have recently weighed in on LMNR shares. BidaskClub raised shares of Limoneira from a “hold” rating to a “buy” rating in a research note on Thursday. Zacks Investment Research upgraded shares of Limoneira from a “hold” rating to a “buy” rating and set a $22.00 target price for the company in a report on Thursday. Finally, ValuEngine raised shares of Limoneira from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 31st. One analyst has rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. The company has an average rating of “Buy” and an average price target of $24.60.
In related news, CEO Harold S. Edwards sold 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $20.24, for a total transaction of $40,480.00. Insiders have sold a total of 5,100 shares of company stock valued at $102,790 over the last three months. 4.50% of the stock is owned by corporate insiders.
A number of hedge funds have recently added to or reduced their stakes in the business. Metropolitan Life Insurance Co NY boosted its stake in shares of Limoneira by 17.3% during the third quarter. Metropolitan Life Insurance Co NY now owns 5,188 shares of the company’s stock valued at $95,000 after purchasing an additional 764 shares during the period. Millennium Management LLC purchased a new position in Limoneira in the 3rd quarter worth about $1,104,000. Ashford Capital Management Inc. lifted its holdings in Limoneira by 2.1% during the 3rd quarter. Ashford Capital Management Inc. now owns 853,792 shares of the company’s stock valued at $15,676,000 after buying an additional 17,862 shares in the last quarter. State Street Corp lifted its holdings in Limoneira by 0.7% during the 3rd quarter. State Street Corp now owns 280,139 shares of the company’s stock valued at $5,143,000 after buying an additional 1,955 shares in the last quarter. Finally, First Trust Advisors LP boosted its position in Limoneira by 29.8% in the 3rd quarter. First Trust Advisors LP now owns 34,674 shares of the company’s stock valued at $637,000 after buying an additional 7,963 shares during the period. Institutional investors and hedge funds own 56.46% of the company’s stock.
Limoneira Company operates as an agribusiness and real estate development company in the United States and internationally. The company operates in six segments: Fresh Lemons, Lemon Packing, Avocados, Other Agribusiness, Rental Operations, and Real Estate Development. It grows, processes, packs, markets, and sells lemons.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Limoneira Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Limoneira and related companies with MarketBeat.com's FREE daily email newsletter.